THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM: AN EFFECT ON PULMONARY PERFUSION (PART 2)
Background. Perfusion scintigraphy reveals perfusion defects in the occlusion of pulmonary vessels of any caliber and makes it possible to quantify pulmonary blood flow disorders, which allows the method to be used for the comparison of the thrombolytic and anticoagulant therapy efficacy in patients...
Main Authors: | O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, O. A. Alekseyechkina, E. V. Kungurtsev, N. M. Udalova, S. Z. Khusainov, I. B. Kostyuchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2018-07-01
|
Series: | Неотложная медицинская помощь |
Subjects: | |
Online Access: | https://www.jnmp.ru/jour/article/view/464 |
Similar Items
-
Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death
by: O. V. Nikitina, et al.
Published: (2018-11-01) -
The possibilities of lung perfusion scintigraphy in the diagnosis of pulmonary embolism and chronic thromboembolic pulmonary hypertension
by: V.Yu. Kundin, et al.
Published: (2017-06-01) -
The diagnostic accuracy of perfusion-only scan in the diagnosis of pulmonary embolism in the era of COVID-19: A single-center study of 434 patients
by: Turgut Bora Cengiz, et al.
Published: (2023-01-01) -
Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial
by: Maryam Taherkhani, et al.
Published: (2015-10-01) -
Value of thrombolytic therapy for submassive pulmonary embolism patients
by: Magda A Ahmed, et al.
Published: (2018-01-01)